196 related articles for article (PubMed ID: 36965901)
21. Post-translational modifications of the ligands: Requirement for TAM receptor activation.
Geng K
Int Rev Cell Mol Biol; 2020; 357():35-55. PubMed ID: 33234244
[TBL] [Abstract][Full Text] [Related]
22. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
[TBL] [Abstract][Full Text] [Related]
23. TAM receptors in phagocytosis: Beyond the mere internalization of particles.
Burstyn-Cohen T; Fresia R
Immunol Rev; 2023 Oct; 319(1):7-26. PubMed ID: 37596991
[TBL] [Abstract][Full Text] [Related]
24. The TAM Subfamily of Receptor Tyrosine Kinases: The Early Years.
Prieto AL; Lai C
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542343
[TBL] [Abstract][Full Text] [Related]
25. Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction.
DeBerge M; Glinton K; Subramanian M; Wilsbacher LD; Rothlin CV; Tabas I; Thorp EB
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33529176
[TBL] [Abstract][Full Text] [Related]
26. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
[TBL] [Abstract][Full Text] [Related]
27. TAM family kinases as therapeutic targets at the interface of cancer and immunity.
DeRyckere D; Huelse JM; Earp HS; Graham DK
Nat Rev Clin Oncol; 2023 Nov; 20(11):755-779. PubMed ID: 37667010
[TBL] [Abstract][Full Text] [Related]
28. The Gas6/TAM System and Multiple Sclerosis.
Bellan M; Pirisi M; Sainaghi PP
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801848
[TBL] [Abstract][Full Text] [Related]
29. Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells.
Lee YJ; Lim T; Han MS; Lee SH; Baek SH; Nan HY; Lee C
Oncol Rep; 2017 Feb; 37(2):1219-1226. PubMed ID: 28035396
[TBL] [Abstract][Full Text] [Related]
30. Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition.
Engelsen AST; Lotsberg ML; Abou Khouzam R; Thiery JP; Lorens JB; Chouaib S; Terry S
Front Immunol; 2022; 13():869676. PubMed ID: 35572601
[TBL] [Abstract][Full Text] [Related]
31. TAM receptors and their ligand-mediated activation: Role in atherosclerosis.
Cai B; Kasikara C
Int Rev Cell Mol Biol; 2020; 357():21-33. PubMed ID: 33234243
[TBL] [Abstract][Full Text] [Related]
32. TAM receptors: A phosphatidylserine receptor family and its implications in viral infections.
Ghosh Roy S
Int Rev Cell Mol Biol; 2020; 357():81-122. PubMed ID: 33234246
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.
Nguyen KQ; Tsou WI; Calarese DA; Kimani SG; Singh S; Hsieh S; Liu Y; Lu B; Wu Y; Garforth SJ; Almo SC; Kotenko SV; Birge RB
J Biol Chem; 2014 Sep; 289(37):25737-49. PubMed ID: 25074939
[TBL] [Abstract][Full Text] [Related]
34. TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration.
Tondo G; Perani D; Comi C
Dis Markers; 2019; 2019():2387614. PubMed ID: 31636733
[TBL] [Abstract][Full Text] [Related]
35. Targeting Gas6/TAM in cancer cells and tumor microenvironment.
Wu G; Ma Z; Cheng Y; Hu W; Deng C; Jiang S; Li T; Chen F; Yang Y
Mol Cancer; 2018 Jan; 17(1):20. PubMed ID: 29386018
[TBL] [Abstract][Full Text] [Related]
36. GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
Tutusaus A; Morales A; García de Frutos P; Marí M
Semin Liver Dis; 2024 Feb; 44(1):99-114. PubMed ID: 38395061
[TBL] [Abstract][Full Text] [Related]
37. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.
Seitz HM; Camenisch TD; Lemke G; Earp HS; Matsushima GK
J Immunol; 2007 May; 178(9):5635-42. PubMed ID: 17442946
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of lung homeostasis and silicosis by the TAM receptors MerTk and Axl.
Guimarães-Pinto K; Leandro M; Corrêa A; Maia EP; Rodrigues L; da Costa ALA; Rafael Machado Ferreira J; Claudio-Etienne E; Siebenlist U; He J; Rigoni TDS; Ferreira TPT; Jannini-Sa YAP; Matos-Guedes HL; Costa-da-Silva AC; Lopes MF; Silva PMR; Kelsall BL; Filardy AA
Front Immunol; 2024; 15():1380628. PubMed ID: 38774866
[TBL] [Abstract][Full Text] [Related]
39. Schwann cells use TAM receptor-mediated phagocytosis in addition to autophagy to clear myelin in a mouse model of nerve injury.
Brosius Lutz A; Chung WS; Sloan SA; Carson GA; Zhou L; Lovelett E; Posada S; Zuchero JB; Barres BA
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):E8072-E8080. PubMed ID: 28874532
[TBL] [Abstract][Full Text] [Related]
40. Immunological role of TAM receptors in the cancer microenvironment.
Gadiyar V; Patel G; Davra V
Int Rev Cell Mol Biol; 2020; 357():57-79. PubMed ID: 33234245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]